Center-Authored Papers

Filters: Author is Kulke, Matthew H  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, Hoskins J, Figlioli G, Mocci E, Collins I, Chung CC et al..  2016.  Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.. Oncotarget. 7(41):66328-66343. Abstract
P
Yao JC, Guthrie KA, Moran C, Strosberg JR, Kulke MH, Chan JA, LoConte N, McWilliams RR, Wolin EM, Mattar B et al..  2017.  Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2016704072. Abstract
G
Wolpin BM, Rizzato C, Kraft P, Kooperberg C, Petersen GM, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Buring J et al..  2014.  Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.. Nature genetics. 46(9):994-1000. Abstract
F
Kulke MH, Siu LL, Tepper JE, Fisher G, Jaffe D, Haller DG, Ellis LM, Benedetti JK, Bergsland EK, Hobday TJ et al..  2011.  Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(7):934-43. Abstract